{"component": "definition", "props": {"groups": [{"size": 19, "samples": [{"hash": "4T92gq40II1", "uri": "https://rules.utah.gov/wp-content/uploads/b20240415.pdf", "label": "rules.utah.gov", "score": 12.1375770569, "published": false}, {"hash": "1j7dGArEMIU", "uri": "https://rules.utah.gov/wp-content/uploads/b20221201.pdf", "label": "rules.utah.gov", "score": 11.4544830322, "published": false}, {"hash": "6iAkeT8wWyl", "uri": "https://rules.utah.gov/wp-content/uploads/b20220715.pdf", "label": "rules.utah.gov", "score": 11.2628335953, "published": false}], "snippet": "means a reasonably homogenous cannabis product in its final packaged form created using the same standard operating procedures and the same formulation.", "snippet_links": [{"key": "cannabis-product", "type": "definition", "offset": [30, 46]}, {"key": "final-packaged-form", "type": "definition", "offset": [54, 73]}, {"key": "standard-operating-procedures", "type": "clause", "offset": [97, 126]}], "hash": "4c2fce3f978115d3ba87e3f53a4dbea3", "id": 1}, {"size": 18, "samples": [{"hash": "6ofKckKh9Bt", "uri": "https://www.in.gov/counties/spencer/files/A00150.pdf", "label": "www.in.gov", "score": 15.4642934799, "published": false}, {"hash": "gVY5AaBojpd", "uri": "http://iac.iga.in.gov/iac/T03270/A00150.PDF", "label": "iac.iga.in.gov", "score": 8.4257354736, "published": false}, {"hash": "7GdiZWnhaDM", "uri": "http://iac.iga.in.gov/iac/iac_title?iact=327&iaca=15", "label": "iac.iga.in.gov", "score": 8.2724161148, "published": false}], "snippet": "means a product that is not used in producing other products and is built and intended for use outdoors, provided the final product has not deteriorated or has otherwise become a potential source of contaminants.", "snippet_links": [{"key": "other-products", "type": "clause", "offset": [46, 60]}, {"key": "intended-for-use", "type": "definition", "offset": [78, 94]}, {"key": "the-final", "type": "clause", "offset": [114, 123]}, {"key": "source-of", "type": "definition", "offset": [189, 198]}], "hash": "00a0e31b27ed2b7b410f62ddbcf87e1c", "id": 2}, {"size": 12, "samples": [{"hash": "lgIpfti2OXb", "uri": "/contracts/lgIpfti2OXb#final-product", "label": "Commercial License Agreement", "score": 31.3408622742, "published": true}, {"hash": "7WIxJVnIh1m", "uri": "/contracts/7WIxJVnIh1m#final-product", "label": "Commercial License Agreement", "score": 31.3408622742, "published": true}, {"hash": "d3o3LWtTkCb", "uri": "/contracts/d3o3LWtTkCb#final-product", "label": "Commercial License Agreement (Oncobiologics, Inc.)", "score": 26.0369606018, "published": true}], "snippet": "means any pharmaceutical preparation in final form containing any Licensed Product(s) for sale by prescription, over-the-counter or any other method, in any dosage form, formulation,", "snippet_links": [{"key": "final-form", "type": "clause", "offset": [40, 50]}, {"key": "for-sale", "type": "clause", "offset": [86, 94]}, {"key": "other-method", "type": "clause", "offset": [136, 148]}, {"key": "dosage-form", "type": "definition", "offset": [157, 168]}], "hash": "9d77f45b3a0cb362813c034a0cf7c6fb", "id": 3}, {"size": 9, "samples": [{"hash": "2fhpjG9rvTm", "uri": "https://jena-optronik.de/en/contact.html?file=tl_files/pdf/Standard%20Terms%20and%20Conditions%20of%20Purchase%20and%20Supply.pdf", "label": "jena-optronik.de", "score": 19.3493423462, "published": false}, {"hash": "8g5nlAx72CI", "uri": "https://jena-optronik.de/de/kontakt.html?file=tl_files/pdf/Standard%20Terms%20and%20Conditions%20of%20Purchase%20and%20Supply.pdf", "label": "jena-optronik.de", "score": 19.2253227234, "published": false}, {"hash": "7UCNX1oCVmN", "uri": "https://www.airbus.com/sites/g/files/jlcbta136/files/2024-10/AD-Ltd-England-and-Wales-GTC-version-Oct2024.pdf", "label": "www.airbus.com", "score": 17.4975204468, "published": false}], "snippet": "means the Purchaser\u2019s products and all variants and derivatives thereof, in which the Items are or could be incorporated.", "snippet_links": [{"key": "the-purchaser", "type": "clause", "offset": [6, 19]}, {"key": "the-items", "type": "definition", "offset": [82, 91]}], "hash": "e13ce20c5bdd6203b4cf5a0fcace60e9", "id": 4}, {"size": 7, "samples": [{"hash": "8spnl2AAhd3", "uri": "https://www.wvlegislature.gov/legisdocs/publications/acts/Acts_2024_Vol_1.pdf", "label": "www.wvlegislature.gov", "score": 19.947347641, "published": false}, {"hash": "fvnYd3iFEMO", "uri": "http://www.wvlegislature.gov/Bill_Text_HTML/2024_SESSIONS/RS/bills/sb679%20sub2.docx", "label": "www.wvlegislature.gov", "score": 19.0474090576, "published": false}, {"hash": "2pKV10SohbS", "uri": "https://www.wvlegislature.gov/Bill_Text_HTML/2024_SESSIONS/RS/bills/sb679%20sub2%20enr.docx", "label": "www.wvlegislature.gov", "score": 18.9051494598, "published": false}], "snippet": "means a product approved by the Department in accordance with the provisions of this article, and any other applicable rules and requirements set forth by the Department, as specified for the product.", "snippet_links": [{"key": "by-the-department", "type": "clause", "offset": [25, 42]}, {"key": "in-accordance-with", "type": "clause", "offset": [43, 61]}, {"key": "provisions-of-this-article", "type": "clause", "offset": [66, 92]}, {"key": "rules-and-requirements", "type": "clause", "offset": [119, 141]}, {"key": "as-specified", "type": "clause", "offset": [171, 183]}, {"key": "the-product", "type": "definition", "offset": [188, 199]}], "hash": "d408904f711436c38f7516dc1bc90bc2", "id": 5}, {"size": 7, "samples": [{"hash": "A2J717QdKv", "uri": "https://www.wvlegislature.gov/Bill_Text_HTML/2024_SESSIONS/RS/bills/sb679%20sub2%20enr.pdf", "label": "www.wvlegislature.gov", "score": 10.0965089798, "published": false}, {"hash": "lkJUO5izQUD", "uri": "https://www.wvlegislature.gov/Bill_Text_HTML/2024_SESSIONS/RS/bills/sb679%20sub2%20eng.pdf", "label": "www.wvlegislature.gov", "score": 10.0759754181, "published": false}, {"hash": "hEKpv9txWU3", "uri": "https://www.wvlegislature.gov/Bill_Text_HTML/2024_SESSIONS/RS/bills/sb679%20sub2.pdf", "label": "www.wvlegislature.gov", "score": 10.0718688965, "published": false}], "snippet": "means a product approved by the Department in accordance with the", "snippet_links": [{"key": "by-the-department", "type": "clause", "offset": [25, 42]}, {"key": "in-accordance-with", "type": "clause", "offset": [43, 61]}], "hash": "93ff704745ef775c0f9fe8924d297d9f", "id": 6}, {"size": 7, "samples": [{"hash": "Dq4VHyNNQ8", "uri": "/contracts/Dq4VHyNNQ8#final-product", "label": "License Agreement (Oscient Pharmaceuticals Corp)", "score": 21.0, "published": true}, {"hash": "6plbaZypTBZ", "uri": "/contracts/6plbaZypTBZ#final-product", "label": "License Agreement (Oscient Pharmaceuticals Corp)", "score": 21.0, "published": true}, {"hash": "4u7yO3YC36e", "uri": "/contracts/4u7yO3YC36e#final-product", "label": "License Agreement (Cornerstone Therapeutics Inc)", "score": 21.0, "published": true}], "snippet": "means the Product in final form for commercialization and distribution, labeled in accordance with applicable regulatory requirements and custom and meeting the Final Product Specifications.", "snippet_links": [{"key": "the-product", "type": "definition", "offset": [6, 17]}, {"key": "final-form", "type": "clause", "offset": [21, 31]}, {"key": "commercialization-and-distribution", "type": "clause", "offset": [36, 70]}, {"key": "in-accordance-with", "type": "clause", "offset": [80, 98]}, {"key": "applicable-regulatory-requirements", "type": "definition", "offset": [99, 133]}, {"key": "final-product-specifications", "type": "definition", "offset": [161, 189]}], "hash": "1ee6e88a19daab3be888e3f557f28f7b", "id": 7}, {"size": 6, "samples": [{"hash": "hrmm9qXvkhf", "uri": "/contracts/hrmm9qXvkhf#final-product", "label": "Commercial Supply Agreement (Horizon Therapeutics Public LTD Co)", "score": 30.1485290527, "published": true}, {"hash": "kRNritUN5Uj", "uri": "/contracts/kRNritUN5Uj#final-product", "label": "Commercial Supply Agreement (Horizon Pharma PLC)", "score": 26.3976726532, "published": true}, {"hash": "hQyNW2JqkCT", "uri": "/contracts/hQyNW2JqkCT#final-product", "label": "Commercial Supply Agreement (Horizon Pharma PLC)", "score": 25.6009578705, "published": true}], "snippet": "means finished Product in its final packaged and labeled form which is ready for distribution to the marketplace or third party distributors for sale or clinical use.", "snippet_links": [{"key": "finished-product", "type": "definition", "offset": [6, 22]}, {"key": "for-distribution", "type": "clause", "offset": [77, 93]}, {"key": "third-party-distributors", "type": "clause", "offset": [116, 140]}, {"key": "for-sale", "type": "clause", "offset": [141, 149]}, {"key": "clinical-use", "type": "definition", "offset": [153, 165]}], "hash": "80fe95b2295cc7f5908f29a82584df9d", "id": 8}, {"size": 5, "samples": [{"hash": "kQHBJnlbb3r", "uri": "https://www3.oklegislature.gov/cf_pdf/2023-24%20SUPPORT%20DOCUMENTS/SCHEDULED%20CCR/House/SB1635%20CCR%20A.PDF", "label": "www3.oklegislature.gov", "score": 17.3247947693, "published": false}, {"hash": "ap6qjri71qP", "uri": "https://www.oklegislature.gov/cf_pdf/2023-24%20COMMITTEE%20AMENDMENTS/House/SB1635%20FULLPCS1%20TJ%20MARTI-GRS.PDF", "label": "www.oklegislature.gov", "score": 17.1752357483, "published": false}, {"hash": "s3mjMH03zg", "uri": "https://www.oklegislature.gov/cf_pdf/2023-24%20AMENDMENTS/Amendment%20and%20Engr/SB1635%20HASB%20AND%20ENGR.PDF", "label": "www.oklegislature.gov", "score": 16.2106685638, "published": false}], "snippet": "means the finished product that is", "snippet_links": [{"key": "finished-product", "type": "definition", "offset": [10, 26]}], "hash": "7d801a7e893cdc8d4b26e70708002392", "id": 9}, {"size": 5, "samples": [{"hash": "luLyFcoRJmI", "uri": "/contracts/luLyFcoRJmI#final-product", "label": "Development & Sub License Agreement (Genta Incorporated /De/)", "score": 18.0, "published": true}, {"hash": "i3Fpvu2S15p", "uri": "/contracts/i3Fpvu2S15p#final-product", "label": "Development & Sub License Agreement (Genta Incorporated /De/)", "score": 18.0, "published": true}, {"hash": "9ldfjDoWiWh", "uri": "/contracts/9ldfjDoWiWh#final-product", "label": "Development & Sub License Agreement (Genta Incorporated /De/)", "score": 18.0, "published": true}], "snippet": "means the pharmaceutical orally-administered controlled-release formulation", "snippet_links": [], "hash": "fb3466a5e524463c94c24831088cd93b", "id": 10}], "next_curs": "CloSVGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjYLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIWZmluYWwtcHJvZHVjdCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Final Product", "size": 191, "snippet": "means a reasonably homogenous cannabis product in its final packaged form created using the same standard operating procedures and the same formulation.", "id": "final-product", "examples": ["To rule on the technical decisions in relation with the definition and development of the <strong>Final Product</strong>.", "For the avoidance of doubt, no royalty payments shall be due for a <strong>Final Product</strong> in a specific country after the Royalty Term has expired for such <strong>Final Product</strong> in such country.", "The Project Managerial Board definition and its related prerogatives detailed in entire Article 4, are applicable only for the development phase up to completion of <strong>Final Product</strong>.", "For <strong>Final Products</strong> covered by more than one SELEXIS Patent Rights, COMPANY will make one payment to SELEXIS for royalties on any unit of <strong>Final Product</strong> sold by COMPANY or Sublicensees, irrespective of how many SELEXIS Patent Rights may cover such <strong>Final Product</strong>.", "Where royalties are due for the sales of <strong>Final Product</strong> by a Sublicensee, payment shall be made within [*] of the end of that Calendar Quarter.", "Nothing in this Agreement shall be construed as a representation made, or warranty given, by GENTA JAGO that any development performed by or for GENTA JAGO under this Agreement will be successful in whole or in part, or that any product, including <strong>Final Product</strong>, which may be developed, will be successful in the commercial marketplace.", "In the event that GENTA JAGO exercises its option to have transferred such <strong>Final Product</strong> IPR from KRYPTON to GENTA JAGO, GENTA JAGO shall maintain such <strong>Final Product</strong> IPR during the term of this Agreement to the extent GENTA JAGO deems commercially reasonable and shall bear all cost associated therewith incurred after the date of GENTA JAGO&#x27;s notice to KRYPTON exercising its option referred to in Section 10.2 (b) above.", "GENTA JAGO shall keep KRYPTON informed on a regular basis on its taking or refraining from taking, and the development of, any of the foregoing actions, and shall consider, in good faith, the interests of KRYPTON under this Agreement when taking any of the foregoing actions, to the extent that any such action or such infringement may have an adverse effect on <strong>Final Product</strong>.", "In such case, the Parties shall negotiate in good faith the terms and condition, under which such <strong>Final Product</strong> IPR transferred to GENTA JAGO shall be included in the License pursuant to Article 11.", "In order to exercise this right, COMPANY shall notify SELEXIS in accordance with Section 11.10 of this Agreement that it is paying the Royalty Termination Fee for all <strong>Final Product</strong> containing the specified Licensed Product in such notice."], "related": [["medicinal-product", "medicinal product", "medicinal product"], ["aerosol-product", "Aerosol Product", "Aerosol Product"], ["approved-product", "Approved Product", "Approved Product"], ["additional-product", "Additional Product", "Additional Product"], ["finished-product", "Finished Product", "Finished Product"]], "related_snippets": [], "updated": "2025-07-17T06:20:50+00:00"}, "json": true, "cursor": ""}}